Medicine and Health

Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study

C. Zheng, H. Lu, et al.

This groundbreaking study by Chuansheng Zheng and colleagues highlights the superior efficacy and safety of combining transarterial chemoembolization (TACE) with sunitinib in treating advanced renal cell carcinoma, showcasing remarkable improvements in response rates and survival outcomes.

00:00

Playback language: English

Index

Abstract

This retrospective study compared the efficacy and safety of transarterial chemoembolization (TACE) combined with sunitinib versus sunitinib alone in treating 98 patients with unresectable advanced renal cell carcinoma (RCC). The TACE + sunitinib group showed significantly higher objective response rate (ORR), disease control rate (DCR), and longer overall survival (OS) and progression-free survival (PFS) compared to the sunitinib-only group. While the TACE + sunitinib group experienced a higher incidence of abdominal pain, fever, and vomiting (post-embolization syndrome), the combination therapy was deemed safe and effective.

Publisher

BMC Cancer

Published On

Mar 20, 2023

Authors

Chuansheng Zheng, Haohao Lu, Qing Ye, Li Fan, Xiangwen Xia

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

The COVID-AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes

G. Giuliani, F. Guerra, et al.

Medicine and Health

Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis

K. Liang, H. Li, et al.

Medicine and Health

A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression

P. R. Shiroma, P. Thuras, et al.

Medicine and Health

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study

J. An, X. Li, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny